Q5: Is semaglutide FDA-approved
Although the APAP toxicity-associated acute liver failure has better outcome than other causes of liver failure, mortality is still significant in 30% of cases without a liver transplant (for those who are deemed in need of a transplant)
Use of a GLP-1glucagon-like peptide-1 receptor agonistwas first approved by the FDA in 2005 for patients with type-2 diabetes, but in 2014 also received FDA approval for obesity treatment
13,14 The most common culprits for weight gain are antiepileptics, antihyperglycemics, antipsychotics, beta-blockers, and glucocorticoids
Some patients even report improved mood as a secondary benefit, particularly those whose depression was partly driven by obesity-related inflammation, sleep apnea, or social isolation that improves with weight loss